ARCHIVES

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

Authorization Legislation Still On Congress Busy Agenda, Along With Risk Assessment, Appropriations

February 3, 1984

Zelboraf Increased Overall Survival To 15.9 Months in Phase II Study

March 30, 2012

NCI Implementing Changes In Organ Site Program, Directing Grant applications To NIH Study Sections

October 15, 1982

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

First Report On Carcinogens Now Avaiable

October 3, 1980

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014